Found: 81
Select item for more details and to access through your institution.
Association of proton pump inhibitor and antibiotic use with the clinical outcomes of hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: A multicenter analysis.
- Published in:
- Hepatology Research, 2023, v. 53, n. 8, p. 737, doi. 10.1111/hepr.13905
- By:
- Publication type:
- Article
Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 5, p. 462, doi. 10.1111/hepr.13748
- By:
- Publication type:
- Article
Lenvatinib versus Sorafenib as first‐line treatment in hepatocellular carcinoma: A multi‐institutional matched case‐control study.
- Published in:
- Hepatology Research, 2021, v. 51, n. 12, p. 1229, doi. 10.1111/hepr.13718
- By:
- Publication type:
- Article
Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression.
- Published in:
- Hepatology Research, 2021, v. 51, n. 8, p. 880, doi. 10.1111/hepr.13644
- By:
- Publication type:
- Article
What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355
- By:
- Publication type:
- Article
EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 6, p. 734, doi. 10.1159/000508971
- By:
- Publication type:
- Article
Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study.
- Published in:
- Hepatitis Monthly, 2013, v. 13, n. 12, p. 1, doi. 10.5812/hepatmon.14872
- By:
- Publication type:
- Article
Serum Lipoprotein Profiles and Response to Pegylated Interferon Plus Ribavirin Combination Therapy in Patients With Chronic HCV Genotype 1b Infection.
- Published in:
- Hepatitis Monthly, 2013, v. 13, n. 5, p. 1, doi. 10.5812/hepatmon.8988
- By:
- Publication type:
- Article
Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinoma.
- Published in:
- Gastroenterology Report, 2021, v. 9, n. 2, p. 133, doi. 10.1093/gastro/goaa042
- By:
- Publication type:
- Article
Hepatocellular organellar abnormalities following elimination of hepatitis C virus.
- Published in:
- Liver International, 2023, v. 43, n. 8, p. 1677, doi. 10.1111/liv.15624
- By:
- Publication type:
- Article
A genome‐wide association study identifying SVEP1 variant as a predictor of response to tolvaptan for cirrhotic ascites.
- Published in:
- Liver International, 2021, v. 41, n. 12, p. 2944, doi. 10.1111/liv.15022
- By:
- Publication type:
- Article
Neutrophil‐to‐lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Liver International, 2020, v. 40, n. 4, p. 968, doi. 10.1111/liv.14405
- By:
- Publication type:
- Article
Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching.
- Published in:
- Hepatology Research, 2020, v. 50, n. 1, p. 75, doi. 10.1111/hepr.13427
- By:
- Publication type:
- Article
Efficacy of direct‐acting antiviral treatment in patients with compensated liver cirrhosis: A multicenter study.
- Published in:
- Hepatology Research, 2019, v. 49, n. 2, p. 125, doi. 10.1111/hepr.13256
- By:
- Publication type:
- Article
Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis.
- Published in:
- Hepatology Research, 2019, v. 49, n. 1, p. 111, doi. 10.1111/hepr.13243
- By:
- Publication type:
- Article
Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease.
- Published in:
- Hepatology Research, 2018, v. 48, n. 7, p. 549, doi. 10.1111/hepr.13058
- By:
- Publication type:
- Article
Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C.
- Published in:
- Hepatology Research, 2017, v. 47, n. 13, p. 1429, doi. 10.1111/hepr.12910
- By:
- Publication type:
- Article
Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy.
- Published in:
- Hepatology Research, 2017, v. 47, n. 12, p. 1308, doi. 10.1111/hepr.12898
- By:
- Publication type:
- Article
Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease.
- Published in:
- Hepatology Research, 2017, v. 47, n. 11, p. 1165, doi. 10.1111/hepr.12879
- By:
- Publication type:
- Article
Association between vitamin D deficiency and pre-existing resistance-associated hepatitis C virus NS5A variants.
- Published in:
- Hepatology Research, 2017, v. 47, n. 7, p. 641, doi. 10.1111/hepr.12784
- By:
- Publication type:
- Article
Is there a survival benefit in interventional radiology for hepatocellular carcinoma in patients with Child-Pugh C liver cirrhosis?: A multicenter study.
- Published in:
- Hepatology Research, 2016, v. 46, n. 6, p. 521, doi. 10.1111/hepr.12583
- By:
- Publication type:
- Article
Effect of native vitamin D<sub>3</sub> supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin.
- Published in:
- Hepatology Research, 2016, v. 46, n. 5, p. 450, doi. 10.1111/hepr.12575
- By:
- Publication type:
- Article
Factors associated with sustained virological response in 24-week telaprevir-based triple therapy for chronic hepatitis C genotype 1b patients with the IL28B minor genotype.
- Published in:
- Hepatology Research, 2015, v. 45, n. 4, p. 387, doi. 10.1111/hepr.12360
- By:
- Publication type:
- Article
A 48-week telaprevir-based triple combination therapy improves sustained virological response rate in previous non-responders to peginterferon and ribavirin with genotype 1b chronic hepatitis C: A multicenter study.
- Published in:
- Hepatology Research, 2014, v. 44, n. 14, p. E386, doi. 10.1111/hepr.12323
- By:
- Publication type:
- Article
Serum 25-hydroxyvitamin D<sub>3</sub> levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load.
- Published in:
- Hepatology Research, 2014, v. 44, n. 13, p. 1277, doi. 10.1111/hepr.12298
- By:
- Publication type:
- Article
Effects of branched-chain amino acid granules on serum albumin level and prognosis are dependent on treatment adherence in patients with liver cirrhosis.
- Published in:
- Hepatology Research, 2013, v. 43, n. 5, p. 459, doi. 10.1111/j.1872-034X.2012.01097.x
- By:
- Publication type:
- Article
Identification of CT Values That Could Be Predictive of Necrosis (N-CTav) in Hepatocellular Carcinoma after Lenvatinib Treatment.
- Published in:
- Current Oncology, 2022, v. 29, n. 5, p. 3259, doi. 10.3390/curroncol29050266
- By:
- Publication type:
- Article
Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era.
- Published in:
- Oncology, 2022, v. 100, n. 2, p. 65, doi. 10.1159/000520292
- By:
- Publication type:
- Article
Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.
- Published in:
- Oncology, 2021, v. 99, n. 8, p. 518, doi. 10.1159/000515896
- By:
- Publication type:
- Article
Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2020, v. 98, n. 5, p. 295, doi. 10.1159/000506293
- By:
- Publication type:
- Article
Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2019, v. 97, n. 6, p. 334, doi. 10.1159/000502095
- By:
- Publication type:
- Article
Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2019, v. 97, n. 5, p. 277, doi. 10.1159/000501281
- By:
- Publication type:
- Article
Occurrence of Hepatocellular Carcinoma Was Not a Rare Event during and Immediately after Antiviral Treatment in Japanese HCV-Positive Patients.
- Published in:
- Oncology, 2011, v. 80, n. 5/6, p. 366, doi. 10.1159/000330549
- By:
- Publication type:
- Article
Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
- Published in:
- Cancer Reports, 2024, v. 7, n. 4, p. 1, doi. 10.1002/cnr2.2042
- By:
- Publication type:
- Article
Evaluation of 8‐week glecaprevir/pibrentasvir treatment in direct‐acting antiviral‐naïve noncirrhotic HCV genotype 1 and 2infected patients in a real‐world setting in Japan.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 11, p. 1266, doi. 10.1111/jvh.13170
- By:
- Publication type:
- Article
The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 9, p. 1230, doi. 10.1111/apt.15218
- By:
- Publication type:
- Article
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 8, p. 3719, doi. 10.1002/cam4.2241
- By:
- Publication type:
- Article
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 1, p. 137, doi. 10.1002/cam4.1909
- By:
- Publication type:
- Article
Predictors of Response to 24-Week Telaprevir-Based Triple Therapy for Treatment-Naive Genotype 1b Chronic Hepatitis C Patients.
- Published in:
- Gastroenterology Research & Practice, 2014, p. 1, doi. 10.1155/2014/549709
- By:
- Publication type:
- Article
Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B.
- Published in:
- JGH Open, 2021, v. 5, n. 1, p. 34, doi. 10.1002/jgh3.12443
- By:
- Publication type:
- Article
Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 5, p. 949, doi. 10.1111/jgh.16494
- By:
- Publication type:
- Article
Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 7, p. 1812, doi. 10.1111/jgh.15336
- By:
- Publication type:
- Article
Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real‐world setting: A large, multicenter study from Japan.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 8, p. 1420, doi. 10.1111/jgh.14982
- By:
- Publication type:
- Article
Real‐world experience of 12‐week direct‐acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 5, p. 855, doi. 10.1111/jgh.14874
- By:
- Publication type:
- Article
Impact of albumin–bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time‐dependent receiver operating characteristic.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 6, p. 1066, doi. 10.1111/jgh.14564
- By:
- Publication type:
- Article
Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 2, p. 364, doi. 10.1111/jgh.14447
- By:
- Publication type:
- Article
Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema.
- Published in:
- Journal of Gastroenterology & Hepatology, 2018, v. 33, n. 6, p. 1256, doi. 10.1111/jgh.14047
- By:
- Publication type:
- Article
Influencing factors on serum 25-hydroxyvitamin D<sub>3</sub> levels in Japanese chronic hepatitis C patients.
- Published in:
- BMC Infectious Diseases, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12879-015-1020-y
- By:
- Publication type:
- Article
Influencing factors on serum 25-hydroxyvitamin D<sub>3</sub> levels in Japanese chronic hepatitis C patients.
- Published in:
- BMC Infectious Diseases, 2015, v. 15, n. 1, p. 344, doi. 10.1186/s12879-015-1020-y
- By:
- Publication type:
- Article
Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin.
- Published in:
- BMC Infectious Diseases, 2012, v. 12, n. 1, p. 1, doi. 10.1186/1471-2334-12-324
- By:
- Publication type:
- Article